Twitter LinkedIn
    Wednesday, May 25
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Funds»PhoreMost closes GBP33m Series B financing
    Funds

    PhoreMost closes GBP33m Series B financing

    March 23, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    PhoreMost, a UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable’, disease targets, has completed an oversubscribed GBP33 million (USD46 million) Series B investment round 

    The round was led by BGF, the UK’s most active growth economy investor, and included new investors XtalPi Inc, Astellas Venture Management, Trend Investment Group and o2h ventures. Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.

    The funding will be used to progress PhoreMost’s preclinical ‘Allosteric PLK1’ collaboration with Sentinel Oncology into the clinic in 2022. The programme is initially targeted towards Glioma. PhoreMost will also progress multiple additional internal first-in-class drug discovery programmes across both oncology and ageing therapeutic indications.

    PhoreMost’s SITESEEKER platform can identify the best new therapeutic targets for any chosen disease setting, and rapidly identify how to develop novel drugs to these targets. This has the potential to significantly increase the diversity of novel treatments for cancer and other unmet diseases. Significantly, PhoreMost has recently deployed SITESEEKER towards the identification of novel E3-ligands, the progression of which has the potential to be highly disruptive within the important new targeted protein degradation therapeutic modality space.

    Read more

    Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals and transactions Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Pantheon passes $2.4bn in private debt secondaries as flagship fund closes at $834m

    May 24, 2022

    Moove acquires PetroChoice from Golden Gate Capital in £479m deal

    May 24, 2022

    Investcorp to invest $400 mn Indian schooling infra

    May 24, 2022

    KKR Leads $200+ Million Growth Investment in Enterprise Identity Protection Leader Semperis

    May 24, 2022

    Comments are closed.

    Other Articles

    Anchin launches emerging manager platform for hedge, private equity, real estate and venture capital Funds

    March 18, 2021

    European Private Equity Deal and Fundraising Activity Near Record Highs in 2020 Despite COVID-19

    January 22, 2021

    Insight Partners raises $20bn for twelfth flagship fund

    February 25, 2022

    Affirm Raises $1.2B, Pricing Above Range In Hot IPO Market

    January 15, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?